Skip to main content

An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults with Glioblastoma at First Recurrence or Progression

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Medicenna Therapeutics, Inc.

Start Date

February 1, 2017

End Date

March 22, 2022
 

Administered By

Duke Cancer Institute

Awarded By

Medicenna Therapeutics, Inc.

Start Date

February 1, 2017

End Date

March 22, 2022